Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-11 Sale | 2024-11-13 4:18 pm | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 59,441 | $32.51 | $1,932,665 | 66,684 (Indirect Direct) | View |
| 2024-11-07 Sale | 2024-11-12 4:44 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 15,558 | $29.91 | $465,286 | 755,194 (Indirect Direct) | View |
| 2024-11-07 Sale | 2024-11-12 4:43 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,020 | $30 | $30,600 | 111,056 (Direct) | View |
| 2024-11-01 Sale | 2024-11-05 4:21 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 3,080 | $27.07 | $83,376 | 112,076 (Direct) | View |
| 2024-10-18 Sale | 2024-10-22 4:30 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 40,000 | $27.69 | $1,107,600 | 3,516,502 (Indirect Direct) | View |
| 2024-09-30 Sale | 2024-10-02 4:37 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 30,000 | $29.03 | $870,900 | 840,893 (Indirect Direct) | View |
| 2024-09-13 Sale | 2024-09-16 4:17 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,020 | $30 | $30,600 | 115,156 (Direct) | View |
| 2024-09-03 Sale | 2024-09-04 6:26 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 3,080 | $25 | $77,007 | 116,176 (Direct) | View |
| 2024-08-20 Sale | 2024-08-22 4:16 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 2,260 | $23.79 | $53,765 | 2,438,411 (Indirect Direct) | View |
| 2024-08-20 Sale | 2024-08-22 4:15 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 1,727 | $23.79 | $41,085 | 870,893 (Indirect Direct) | View |
| 2024-08-20 Sale | 2024-08-22 4:14 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 8,353 | $23.99 | $200,401 | 701,815 (Indirect Direct) | View |
| 2024-08-20 Sale | 2024-08-22 4:14 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 22,458 | $24.49 | $549,928 | 327,029 (Indirect Direct) | View |
| 2024-08-13 Sale | 2024-08-15 4:10 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 2,272 | $22.89 | $52,006 | 710,168 (Indirect Direct) | View |
| 2024-08-13 Sale | 2024-08-15 4:09 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 2,337 | $22.89 | $53,494 | 349,487 (Indirect Direct) | View |
| 2024-06-13 Sale | 2024-07-03 9:13 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 30,688 | $22.11 | $678,660 | 872,620 (Indirect Direct) | View |
| 2024-07-01 Sale | 2024-07-03 9:13 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 3,080 | $22.14 | $68,204 | 119,256 (Direct) | View |
| 2024-06-06 Sale | 2024-06-10 8:06 pm | Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director | 1,458 | $21.73 | $31,682 | 20,038 (Direct) | View |
| 2024-05-15 Sale | 2024-05-17 4:28 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,674 | $20.39 | $34,133 | 116,369 (Direct) | View |
| 2024-04-15 Sale | 2024-04-17 5:14 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $18.29 | $30,471 | 118,043 (Direct) | View |
| 2024-04-01 Sale | 2024-04-02 6:07 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 92,500 | $20.5 | $1,896,250 | 897,341 (Indirect Direct) | View |
| 2024-03-15 Sale | 2024-03-19 4:27 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $20.1 | $33,487 | 119,709 (Direct) | View |
| 2024-02-15 Sale | 2024-02-20 5:38 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $18.37 | $30,604 | 121,375 (Direct) | View |
| 2024-02-13 Sale | 2024-02-15 9:16 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 2,750 | $17.29 | $47,548 | 989,841 (Indirect Direct) | View |
| 2024-02-13 Sale | 2024-02-15 9:15 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 9,589 | $17.29 | $165,794 | 2,480,671 (Indirect Direct) | View |
| 2024-02-13 Sale | 2024-02-15 9:14 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 4,189 | $17.46 | $73,130 | 351,824 (Indirect Direct) | View |
| 2024-02-13 Sale | 2024-02-15 9:14 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 22,844 | $17.62 | $402,420 | 711,090 (Indirect Direct) | View |
| 2024-01-16 Sale | 2024-01-18 6:26 pm | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 1,666 | $18.42 | $30,688 | 123,041 (Direct) | View |
| 2024-01-10 Sale | 2024-01-12 8:18 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 4,668 | $19.02 | $88,785 | 356,013 (Indirect Direct) | View |
| 2024-01-09 Sale | 2024-01-11 5:28 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 7,818 | $19.78 | $154,640 | 2,490,260 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-11 Exercise | 2024-11-13 4:18 pm | N/A 2027-12-06 | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 47,165 | $0 | 66,684 (Direct) | View |
| 2024-11-11 Exercise | 2024-11-13 4:18 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 47,165 | $18 | 66,684 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-12 4:44 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 15,558 | $5.28 | 755,194 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-12 4:44 pm | N/A 2027-03-07 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 15,558 | $0 | 755,194 (Direct) | View |
| 2024-10-18 Exercise | 2024-10-22 4:30 pm | N/A 2025-08-20 | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 40,000 | $0 | 3,516,502 (Direct) | View |
| 2024-10-18 Exercise | 2024-10-22 4:30 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 40,000 | $0.68 | 3,516,502 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:33 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 23,868 | $0 | 921,209 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:32 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Thornberry Nancy Director | 23,868 | $0 | 36,581 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:31 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 23,868 | $0 | 2,135,309 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:30 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 23,868 | $0 | 140,237 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:30 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director | 23,868 | $0 | 39,397 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:29 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 23,868 | $0 | 96,861 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:28 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | FLATLEY JAY T Director | 23,868 | $0 | 364,397 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:27 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Harris Erik Director | 23,868 | $0 | 34,953 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:20 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Klein Peter S Director | 23,868 | $0 | 39,397 (Direct) | View |
| 2024-03-29 Gift | 2024-03-29 5:59 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO | 40,000 | $0 | 2,440,671 (Indirect) | View |
| 2024-02-08 Exercise | 2024-02-12 4:48 pm | N/A 2025-08-20 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 50,000 | $0 | 879,012 (Direct) | View |
| 2024-02-08 Exercise | 2024-02-12 4:48 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary | 50,000 | $0.68 | 879,012 (Direct) | View |